Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated August 21, 2009, and published in the 
                    **Federal Register**
                     on September 8, 2009 (74 FR 46232), Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug
ScheduleMethcathinone (1237)
IN-Ethylamphetamine (1475)
IN,N-Dimethylamphetamine (1480)
I4-Methylaminorex (cis isomer) (1590)
IAlpha-ethyltryptamine (7249)
ILysergic acid diethylamide (7315)
I2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348)
ITetrahydrocannabinols (7370)
IMescaline (7381)
I4-Bromo-2,5-dimethoxyamphetamine (7391)
I4-Bromo-2,5-dimethoxyphenethylamine (7392)
I4-Methyl-2,5-dimethoxyamphetamine (7395)
I2,5-Dimethoxyamphetamine (7396)
I2,5-Dimethoxy-4-ethylamphetamine (7399)
I3,4-Methylenedioxyamphetamine (7400)
IN-Hydroxy-3,4-methylenedioxyamphetamine (7402)
I3,4-Methylenedioxy-N-ethylamphetamine (7404)
I3,4-Methylenedioxymethamphetamine (MDMA) (7405)
I4-Methoxyamphetamine (7411)
IAlpha-methyltryptamine (7432)
IBufotenine (7433)
IDiethyltryptamine (7434)
IDimethyltryptamine (7435)
IPsilocybin (7437)
IPsilocyn (7438)
I5-Methoxy-N,N-diisopropyltryptamine (7439)
IN-Ethyl-1-phenylcyclohexylamine (7455)
I1-(1-Phenylcyclohexyl)pyrrolidine (7458)
I1-Phenylcyclohexylamine (7460)
I1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)
INormorphine (9313)
IMethamphetamine (1105)
IIPhencyclidine (7471)
IIPhenylacetone (8501)
II( print page 2161)1-Piperidinocyclohexane- carbonitrile (8603)
IICocaine (9041)
IICodeine (9050)
IIDihydrocodeine (9120)
IIDihydromorphine (9145)
IIEcgonine (9180)
IIMeperidine intermediate-B (9233)
IINoroxymorphone (9668)
II
 The company plans to manufacture high purity drug standards used for analytical application only in clinical, toxicological, and forensic laboratories. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Alltech Associates to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Alltech Associates to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: January 6, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2010-512 Filed 1-13-10; 8:45 am] BILLING CODE 4410-09-P